NEW YORK, Jan 9, 2026, 11:30 EST — Regular session
BellRing Brands’ shares were down about 0.1% at $24.73 in late-morning trading after TD Cowen cut its 12-month price target to $27 from $31 and kept a Hold rating, meaning it does not see a clear case to buy at current levels. (MarketBeat)
The call matters now because BellRing has been trading closer to its lows than its highs, leaving investors sensitive to any fresh valuation resets from Wall Street. The stock’s 52-week range runs from $22.45 to $80.67. (Nasdaq)
TD Cowen analyst Robert Moskow framed the move as part of a broader 2026 refresh for consumer staples, calling the year “challenging,” with volume growth unlikely to improve much and pricing “muted.” (TipRanks)
The broader sector was firmer, with the Consumer Staples Select Sector SPDR Fund up about 0.4%, even as BellRing edged lower.
Legal headlines have also crept back into the tape. Bragar Eagel & Squire and Bleichmar Fonti & Auld each published new notices this week saying they were investigating potential claims tied to BellRing, without any court finding of wrongdoing. (GlobeNewswire)
BellRing sells nutrition products under brands including Premier Protein, Dymatize and PowerBar, spanning ready-to-drink protein shakes and powders. (Post Holdings)
Investors are also watching for the next earnings date to firm up. The company has not announced a schedule on its own site, and third-party calendars currently cluster the report in early February. (Market Chameleon)
But a target cut does not set the trade. If demand or pricing proves softer than investors expect, another round of estimate trims could follow, while any escalation from investigation notices into actual litigation could keep a lid on sentiment.
The next hard catalyst is BellRing’s fiscal first-quarter update, with market calendars pointing to a Feb. 2 window for results and a call the following day, though the company has yet to confirm timing. (MarketBeat)
